Looking downstream of sarcoma-associated chimeric transcription factors: when is a target really a target?
Mercado
Gabriela E
GE
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6082, USA.
Barr
Frederic G
FG
D000818:Animals; D015815:Cell Adhesion Molecules / Q000235:genetics / Q000378:metabolism; D045744:Cell Line, Tumor; D047369:Chromatin Immunoprecipitation; D018390:Gene Targeting; D006801:Humans; D051379:Mice; D041681:NIH 3T3 Cells; D016376:Oligonucleotides, Antisense / Q000494:pharmacology; D015514:Oncogene Proteins, Fusion / Q000235:genetics* / Q000378:metabolism; D011401:Promoter Regions, Genetic; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism; D050784:Proto-Oncogene Protein c-ets-1 / Q000235:genetics* / Q000378:metabolism; D034802:RNA-Binding Protein EWS / Q000235:genetics* / Q000378:metabolism; D012190:Retroviridae / Q000235:genetics; D012512:Sarcoma, Ewing / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D014157:Transcription Factors / Q000235:genetics* / Q000378:metabolism; D014178:Translocation, Genetic; D000097794:Kalinin
D015815:Cell Adhesion Molecules; D016376:Oligonucleotides, Antisense; D015514:Oncogene Proteins, Fusion; D020033:Protein Isoforms; D050784:Proto-Oncogene Protein c-ets-1; D034802:RNA-Binding Protein EWS; D014157:Transcription Factors; D000097794:Kalinin